Has Denotra Gaillard received payments from drug or device companies?

Yes. Drug and device makers reported $3,013 in general payments to Denotra Gaillard across 32 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Denotra Gaillard did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Denotra Gaillard come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Denotra Gaillard

Women's Health Care, Ambulatory · Columbus, GANPI 1184757049

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 10.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,403, 4.9 times the $287 reported in 2021.

$3,013in general payments, 2019–2025

Across 32 payments — averaging $94.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$326
Sanofi-aventis U.S. LLC$201
Neurocrine Biosciences, Inc.$200
Bayer$198
AbbVie$155
Abbott$153
plus $2K from 19 others

What the payments were for

Food & beverage$3,013100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	3	$326
Sanofi-aventis U.S. LLC	2	$201
Neurocrine Biosciences, Inc.	2	$200
Bayer	2	$198
AbbVie	2	$155
Abbott	1	$153
Pharmacosmos Therapeutics Inc.	1	$149
Gilead	2	$144
E.r. Squibb & Sons, L.L.C.	1	$126
Eisai Inc.	1	$125
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$125
Axsome Therapeutics, Inc.	1	$124
Lexicon Pharmaceuticals, Inc.	1	$124
Teva Pharmaceuticals USA, Inc.	1	$119
Inspire Medical Systems, Inc.	1	$119
Dexcom, Inc.	1	$115
Novo Nordisk	1	$113
Amgen	1	$103
Sage Therapeutics, LLC	1	$100
Vanda Pharmaceuticals Inc.	1	$93
Boehringer Ingelheim	1	$32
Viiv Healthcare Company	1	$21
Merck	1	$19
Theratechnologies Inc.	1	$17
EMD Serono, Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few women's health care, ambulatory providers in Georgiato place this figure against a meaningful peer group, so we don't.

Other women's health care, ambulatory in Columbus

Jennifer McKinneyMarietta$850
Sofia JamalLawrenceville$782
Tomeika WimbushAugusta$674
Diane RobillardMartinez$122
Lori ReiterAtlanta$118
Cameron MatthewsAtlanta$31
Briana HowardCanton$27
Susan DudleyRinggold$21

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →